Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Amgen
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00858364
First received: March 5, 2009
Last updated: November 2, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2021
  Estimated Primary Completion Date: April 2021 (Final data collection date for primary outcome measure)